18F-FDG PET/CT for Response Assessment in Lung Cancer

Charles Marcus, Shahein H. Tajmir, Steven P. Rowe, Sara Sheikhbahaei, Lilja B. Solnes

Research output: Contribution to journalReview articlepeer-review


Treatment response assessment in lung cancer is crucial in the management strategy and outcome of patients. Accurate treatment response assessment can guide the treating physicians and improve patient survival. Anatomic and metabolic tumor response assessments have been evaluated extensively, showing a positive impact in the management of these patients. 18F-FDG PET/CT provides early and more specific treatment response assessments, preceding anatomic changes in these tumors. Familiarity with the different treatment response assessment algorithms, criteria, time intervals, imaging pitfalls is essential for treating physicians and nuclear radiologists to provide accurate response assessments. Artificial Intelligence is being more frequently explored for this purpose and can assist physicians in providing prompt and accurate treatment response assessments.

Original languageEnglish (US)
Pages (from-to)662-672
Number of pages11
JournalSeminars in Nuclear Medicine
Issue number6
StatePublished - Nov 2022

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of '18F-FDG PET/CT for Response Assessment in Lung Cancer'. Together they form a unique fingerprint.

Cite this